You are now being logged in using your Facebook credentials

UKidney: Official Educational Partner of the International Society of Nephrology (ISN)

Login With Facebook
Return to:
Thursday, 12 March 2009 05:00

Evaluation of Rasilez (aliskiren) with epilogue on ONTARGET trial

Written by 
Rate this item
(0 votes)

Evaluation of Rasilez with Epilogue on ONTARGET trial

 

 

 

 

Read 1965 times Last modified on Thursday, 04 March 2010 20:07
Published in Hypertension
Tagged under
Dr. Jordan Weinstein

Latest from Dr. Jordan Weinstein

More in this category: « Current Trends and Controversies in the Diagnosis and Treatment of Hypertension Olmesartan: Exploring a new antihypertensive »

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

back to top